Pharmacology · Anticoagulants, Antiplatelets and Thrombolytics

Unfractionated heparin therapy is conventionally monitored by activated partial thromboplastin time (aPTT), targeting 1.5 to 2.5 times the control value. In which situation is the aPTT unreliable and an anti-Xa assay preferred?

  • A Presence of lupus anticoagulant or very high heparin doses
  • B Concurrent aspirin therapy
  • C Recent clopidogrel loading
  • D Mild thrombocytopenia unrelated to heparin
Correct answer: A. Presence of lupus anticoagulant or very high heparin doses

Explanation

Lupus anticoagulant prolongs phospholipid-dependent clotting tests including aPTT independently of heparin, and at high heparin concentrations the aPTT plateaus, so both situations give misleading values. The chromogenic anti-Xa assay measures heparin activity directly and is unaffected. Antiplatelet drugs such as aspirin and clopidogrel act on platelets and do not distort the aPTT-based heparin monitoring.

Reference: Harrison's Principles of Internal Medicine, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Anticoagulants, Antiplatelets and Thrombolytics MCQs

See all Anticoagulants, Antiplatelets and Thrombolytics MCQs →